Phase 2
N=376
Enhancing Prevention Capacity With Developmental Assets and Getting to Outcomes
Substance Abuse
Bottom Line
View on ClinicalTrials.gov: NCT00780338 ↗Enrolled (actual)
376
Serious AEs
0.0%
Results posted
May 2015
Primary outcome: Primary: Prevention Capacity-GTO Efficacy (Intent to Treat) — 63.38; 59.79; 61.37; 58.71 percentage of the highest possible score — p=.58
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Assets Getting To Outcomes (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- RAND
- Primary completion
- Jan 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Prevention Capacity-GTO Efficacy (Intent to Treat) |
63.38; 59.79; 61.37; 58.71; 59.36; 57.63 | .58 |
| PRIMARY Prevention Capacity - GTO Behaviors (Intent to Treat) |
58.51; 53.88; 57.17; 51.75; 55.82; 49.62 | .61 |
| PRIMARY Prevention Capacity - ASSETS GTO Behaviors (Intent to Treat) |
40.92; 38.44; 42.25; 38.47; 43.59; 38.5 | .45 |
| PRIMARY Prevention Capacity - ASSETS Behaviors (Intent to Treat) |
49.35; 48.72; 49.64; 48.22; 49.94; 47.72 | .65 |
| PRIMARY Prevention Capacity-Assets Efficacy (Intent to Treat) |
58.95; 53.94; 60.68; 56.55; 62.41; 59.16 | .61 |
| SECONDARY Prevention Performance - Total Score (Descriptive Means) |
3.95; 3.95; 3.81; 3.22; 3.62; 3.46 | — |
| SECONDARY Prevention Capacity - GTO Behavior - (User v Non-User Analysis) |
61.24; 59.01; 60.82; 54.56; 60.40; 50.12 | .09 |
| SECONDARY Prevention Capacity - GTO Efficacy (User vs Non-user Analyses) |
62.57; 66.83; 62.79; 60.18; 63.01; 53.54 | .01 sig |
| SECONDARY Prevention Capacity - ASSETS GTO BEHAVIORS (User vs Non-user Analyses) |
40.7; 44.29; 44.86; 39.17; 49.02; 34.04 | .00 sig |
| SECONDARY Prevention Capacity - Assets Behavior - (User v Non-User Analysis) |
50.09; 52.5; 52.48; 47.55; 54.86; 42.6 | .00 sig |
| SECONDARY Prevention Capacity - Assets Efficacy (User vs Non-user Analyses) |
62.61; 60.46; 65.49; 57.25; 68.38; 54.05 | .02 sig |
| SECONDARY Prevention Performance - Total Score (Percent Change) |
-2.77; -18.35; -3.88; 12.71; -6.76; -11.38 | — |
Summary
Alcohol and other drug use among youth is costly for communities. More research is needed about how to best support community based prevention programs and how community prevention expertise can inform the research process. The National Institute on Drug Abuse has funded a 5 year collaboration of the RAND Corporation, Search Institute and its training division, Vision Training Associates, Communities for Children and Youth, and the University of Southern Maine to implement and assess the impact on prevention coalitions, the combination of two complimentary, community-based interventions: Developmental Assets, which supports community mobilization and collaboration to promote positive youth development, and Getting To Outcomes (GTO), which enhances community capacity to complete critical prevention tasks (e.g., evaluation). The purpose of the project is to investigate: 1) How well is the Assets-GTO intervention delivered, how much is it used, and what coalitions think about it; 2) The extent to which the Assets-GTO approach enhances the prevention capacity (knowledge, attitudes, and skills) of individual coalition members and the quality of prevention performance; and 3) Whether enhanced prevention capacity improves alcohol and drug outcomes among youth. Twelve community-based prevention coalitions in Maine (part of Communities for Children and Youth) will participate. Six coalitions-determined at random-will receive manuals, training, and on-site technical assistance consisting of bi-Weekly meetings between A-GTO 4 ME! and key coalition staff. The other six coalitions will continue practice as usual, but will receive an abbreviated version of the Assets-GTO intervention near the end of the project. A Community Research Workgroup made of coalition representatives will review all aspects of the study and interim findings and facilitate dissemination on A-GTO 4 ME! The project will demonstrate and evaluate strategies to strengthen the prevention capacity of community organizations that can be used broadly across many types of programs.
Eligibility Criteria
Inclusion Criteria
Related to the programs of the 12 participating coalitions, the inclusion criterion is being an AOD-related universal, selective, or indicated prevention program or initiative.
Exclusion Criteria
The exclusion criterion is being a case identification, treatment, or after-care program.
Data sourced from ClinicalTrials.gov (NCT00780338). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.